Companies
PINS Medical
its implantable deep brain neurostimulation system received NMPA market approval, reported across multiple Chinese outlets in December 2025; the company separately received an innovation green-channel designation for a deep brain stimulator targeting treatment-resistant obsessive-compulsive disorder in September 2025,…
- Country
- China
NMPA approved
Deep brain stimulation
cn
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Headcount | 101-500 employees (465 reported in 2025 annual report) medium confidence | qiye.qizhidao.com · vcbeathealth.com |
| Certification | CE certification (obtained in October 2016) | pinsmedical.com · vcbeathealth.com |
| Regulatory approval | NMPA approval for four innovative deep brain stimulation products (May 2024) | english.nmpa.gov.cn · pinsmedical.com |
| Regulatory approval | Class III medical device registration certificate for 3.0T MRI-Compatible Bluetooth Sensing Brain Stimulator (March 2023) | pinsmedical.com · vcbeathealth.com |
| Production site | Beijing, China (Building 19, Cloud Valley Park, No.79, Shuangying West Road, Zhongguancun Changping Science Park) | pinsmedical.com |
| Production site | Beijing, China (No. 2, Bolin Road, Beijing Economic-Technological Development Area) | en.pinsmedical.com |
Independent sources: english.nmpa.gov.cn · qiye.qizhidao.com · vcbeathealth.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioelectronic medicine & neuromodulation | regenerative-personalized | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.